Abstract：
OBJECTIVE: This study aimed to determine improvement in health-related quality of life (HRQoL) using a validated disease-specific patient-reported outcome measure (PROM) questionnaire in patients undergoing bone-conduction hearing implant (BCHI) insertion.
METHODS: A mixed retrospective and prospective correlational study.
METHODS: Single tertiary referral center in the United Kingdom.
METHODS: All adult patients undergoing their first BCHI over 6 years (April 1, 2017, to March 3, 2023).
METHODS: The Chronic Otitis Media Benefit Inventory (COMBI) score (postintervention) and the Glasgow Health Status Inventory (GHSI) (pre-and post-BCHI questionnaire).
RESULTS: Improvements were seen across all COMBI domains. The mean total COMBI score was 46.3 (standard deviation = 5.3). Although expected significant improvements were seen in hearing and social domains, there were also notable gains in ear symptoms and reduced medical intervention post-BCHI. There was a statistically significant improvement in all GHSI scores post-BCHI (median total difference 67.1, p < 0.0001).
CONCLUSIONS: This study reports very favorable outcomes for BCHI patients using two different PROMs: COMBI and GHSI. Although these PROMs complement each other, they also offer different perspectives on the same cohort of patients, with COMBI providing a unique insight into specific ear symptoms. This is the first reported study using this complement of PROMS in BCHI patients and offers further evidence for the wide-reaching improvements BCHI can have for patients.
METHODS: A mixed retrospective and prospective correlational study.
METHODS: Single tertiary referral center in the United Kingdom.
METHODS: All adult patients undergoing their first BCHI over 6 years (April 1, 2017, to March 3, 2023).
METHODS: The Chronic Otitis Media Benefit Inventory (COMBI) score (postintervention) and the Glasgow Health Status Inventory (GHSI) (pre-and post-BCHI questionnaire).
RESULTS: Improvements were seen across all COMBI domains. The mean total COMBI score was 46.3 (standard deviation = 5.3). Although expected significant improvements were seen in hearing and social domains, there were also notable gains in ear symptoms and reduced medical intervention post-BCHI. There was a statistically significant improvement in all GHSI scores post-BCHI (median total difference 67.1, p < 0.0001).
CONCLUSIONS: This study reports very favorable outcomes for BCHI patients using two different PROMs: COMBI and GHSI. Although these PROMs complement each other, they also offer different perspectives on the same cohort of patients, with COMBI providing a unique insight into specific ear symptoms. This is the first reported study using this complement of PROMS in BCHI patients and offers further evidence for the wide-reaching improvements BCHI can have for patients.
摘要：
目的：本研究旨在使用经过验证的疾病特异性患者报告结果测量（PROM）问卷，确定骨传导听力植入（BCHI）患者的健康相关生活质量（HRQoL）的改善。
方法：一项混合的回顾性和前瞻性相关研究。
方法：英国的单一三级转诊中心。
方法：所有接受首次BCHI超过6年（2017年4月1日至2023年3月3日）的成年患者。
方法：慢性中耳炎获益量表（COMBI）评分（干预后）和格拉斯哥健康状况量表（GHSI）（BCHI前后问卷）。
结果：在所有COMBI领域都有改善。平均总COMBI评分为46.3(标准偏差=5.3)。尽管在听力和社交领域看到了预期的显着改善，BCHI后,耳部症状也显著增加,医疗干预减少.BCHI后所有GHSI评分均有统计学上的显着改善（中位数总差异67.1，p<0.0001）。
结论：本研究报告BCHI患者使用两种不同的PROM：COMBI和GHSI，结果非常有利。虽然这些PROM相互补充，他们还对同一批患者提供不同的观点，COMBI提供了对特定耳朵症状的独特见解。这是首次报道在BCHI患者中使用这种PROMS补充的研究，并为BCHI对患者的广泛改善提供了进一步的证据。
方法：一项混合的回顾性和前瞻性相关研究。
方法：英国的单一三级转诊中心。
方法：所有接受首次BCHI超过6年（2017年4月1日至2023年3月3日）的成年患者。
方法：慢性中耳炎获益量表（COMBI）评分（干预后）和格拉斯哥健康状况量表（GHSI）（BCHI前后问卷）。
结果：在所有COMBI领域都有改善。平均总COMBI评分为46.3(标准偏差=5.3)。尽管在听力和社交领域看到了预期的显着改善，BCHI后,耳部症状也显著增加,医疗干预减少.BCHI后所有GHSI评分均有统计学上的显着改善（中位数总差异67.1，p<0.0001）。
结论：本研究报告BCHI患者使用两种不同的PROM：COMBI和GHSI，结果非常有利。虽然这些PROM相互补充，他们还对同一批患者提供不同的观点，COMBI提供了对特定耳朵症状的独特见解。这是首次报道在BCHI患者中使用这种PROMS补充的研究，并为BCHI对患者的广泛改善提供了进一步的证据。
